During the past decade, Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 9 clinical trials were completed, i.e. on average, 900% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 2 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Merrimack Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital" are "Breast Cancer" (4 trials), "Prostate Cancer" (2 trials), "Breast Adenocarcinoma" (1 trials), "Cardiac Toxicity" (1 trials) and "Chemotherapeutic Agent Toxicity" (1 trials). Many other conditions were trialed in "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital" in a lesser frequency.

Most popular intervention types in "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital" are "Drug" (9 trials), "Other" (3 trials), "Radiation" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "docetaxel" (2 trials), "3-dimensional conformal accelerated partial breast irradiation" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital" are 7 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".